Caixin
May 05, 2023 08:00 AM

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s Net Profit Dropped 19.1% in First Quarter of 2023

00:00
00:00/00:00
Listen to this article 1x

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (浙江莎普爱思药业股份有限公司) (603168.SH) reported a net profit of 22.4 million yuan in the first quarter of 2023, down 19.1% year-on-year.

Meanwhile, the company posted 162.2 million yuan in revenue, up 8.6% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 261.6 million yuan in total liabilities, with a liability-to-asset ratio of 13.1%.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Save an extra $50. Introductory offer for new readers. Subscribe now.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning
00:00
00:00/00:00